RENAISSANCE TECHNOLOGIES LLC
Position in MDGL — Madrigal Pharmaceuticals, Inc.
CIK 1037389
NEW YORK, NY
Position in MDGL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$24,668,556
-$12,953,232 QoQ
Shares Held
45,942
-36.1% QoQ
Ownership
0.199%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#65
of 411 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MDGL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,952,606,887 across 312 Biotechnology names. MDGL ranks #30 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in MDGL
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,668,556 | 45,942 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $37,621,788 | 71,870 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $48,836,197 | 83,862 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $55,352,006 | 120,682 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $3,279,407 | 10,836 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $28,183,035 | 85,086 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $49,612,501 | 160,782 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $9,443,153 | 44,497 | Shares | Sole | 2024-11-13 | |
| 2023-09-30 | $9,942,695 | 68,082 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $18,175,542 | 78,682 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $42,488,043 | 175,382 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,329,925 | 4,582 | Shares | Sole | 2023-02-13 | |
| 2022-03-31 | $470,976 | 4,800 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $203,376 | 2,400 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,365,286 | 17,111 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $5,160,976 | 52,982 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $4,009,965 | 34,282 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $3,783,448 | 34,033 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $2,586,176 | 21,782 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $8,197,261 | 72,382 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,767,938 | 26,482 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||